Today on Mercalis in Motion, we’re pleased to share a two-part episode featuring three of our colleagues from Triangle Insights Group by Mercalis. Triangle, acquired by Mercalis in April 2022, is a premier strategy consulting firm providing guidance on critical business issues to life science industry leaders. On this episode, Matt Haynes and Meghna Shankar discuss a recent white paper titled “The Indirect Impacts of the Inflation Reduction Act on Pharmaceutical Pipeline and Portfolio Strategy”, co-authored by Shankar and Triangle Principal Megan Thomas. Then, Landy speaks with Triangle Executive Vice President & General Manager Rohit Kumar, who recently joined the company in November 2023. Kumar discusses what brought him to Triangle and shares his vision for the firm and how it will continue to integrate with Mercalis and Policy Reporter to provide value to life sciences companies.
Apr 12, 2024
34 min
Rare Disease Day is an observance that takes place worldwide to raise awareness for rare diseases and improve access to treatment and medical representation for individuals with rare diseases and their families. Rare Disease Day typically takes place on or near the last day of February. In this episode of Mercalis in Motion, Landy and Eric welcome to the studio two guests from Catalyst Pharmaceuticals — Amy Grover, Senior Director of Patient Advocacy and Carrie Ostrea, Senior Manager of Patient Advocacy. We are also joined by our Mercalis colleague John Katter, who serves as a Director, Business Development. Please join us as Amy, Carrie, and John discuss the importance of acknowledging the rare disease community and highlight the work that Catalyst and Mercalis have done for this very important patient population.
Mar 12, 2024
38 min
Mercalis CEO Scott Dulitz joins Landy and Eric for Mercalis in Motion’s first podcast episode of 2024. Scott reflects on a very eventful and successful 2023 as well as what lies ahead for the life sciences commercialization partner in 2024 and beyond.
Feb 12, 2024
31 min
In this episode, our hosts Landy Townsend, Vice President of Marketing and Communications, and Eric Manning, Creative Director, take a look back at 2023, highlighting notable guests and key discussions from the past 12 months. No frills or fluff—just a recap of some of the people and topics that made an impact. Whether you're a regular listener or just tuning in, join us for a review of the conversations that shaped our year.
Dec 18, 2023
28 min
Copay accumulators have been a major topic of discussion in the life sciences community for the past several years, and Mercalis has been extremely busy providing continued guidance and support to our clients who have been impacted. After several recent legal developments, we decided to devote an episode of our Mercalis in Motion podcast to discuss the latest updates via a roundtable discussion. We welcomed to the studio our colleague Michael Harris, Mercalis’ VP of Patient Support Services Strategy. He was joined by Carl Schmid, the Executive Director at the HIV + Hepatitis Policy Institute and Bill Sarraille, a Partner with the Sidley law firm in Washington, D.C. This information will be very helpful to life sciences decision makers who are planning for 2024 and beyond.
Dec 15, 2023
31 min
In this episode of Mercalis in Motion, we welcome to the studio Mercalis CEO Scott Dulitz to discuss TrialCard’s recent rebranding initiative that resulted in the creation of Mercalis. Scott discusses the reasons that led to the rebranding, how we arrived at the name Mercalis, and what’s next for the growing integrated life sciences commercialization partner.
Nov 20, 2023
28 min
Diana Villanova, TrialCard’s VP of Patient Support Services Strategy, joins Landy and Eric on today’s episode, to discuss Alternate Funding Programs (AFPs). Designed to limit plan sponsors’ financial exposure, the increased use of AFPs has introduced new access challenges for patients, plans, and manufacturers alike.
Sep 6, 2023
24 min
The Drug Provisions within the Inflation Reduction Act (IRA) of 2022 are of critical importance to pharmaceutical manufacturers, who now have a host of new considerations when thinking through their portfolio strategies and pricing and market access considerations. In this episode of TrialCard TALK, Landy and Eric welcome to the studio two experts on the topic: Megan Thomas, Partner, Triangle Insights Group and Jason Zemcik, Principal Consultant for Policy Reporter.
Jul 19, 2023
31 min
In this episode of TrialCard TALK, we welcome to the studio Chris Harris, TrialCard's Vice President of Operations, to discuss the growth and impact that TrialCard's non-commercial dispensing pharmacy has had on the organization and its clients.
May 31, 2023
41 min
In this episode of TrialCard TALK, Landy and Eric welcome to the studio Dean Erhardt, President & CEO of D2 Solutions. D2 is a healthcare solutions company that leverages consulting expertise with SaaS-based technology tools to drive revenue, enhance operational efficiency, and decrease exposure to regulatory risk for pharma and biotech manufacturers, specialty pharmacies, payers, and hospitals/IDNs. Mr. Erhardt has over 30 years of strategic marketing and management experience across both the consumer product and pharmaceutical arenas. His experience has spanned several Fortune 500 organizations, including Express Scripts, Cardinal Health, and U.S. Healthcare.Download this episode to learn more about the everchanging healthcare landscape and what Mr. Erhardt sees ahead for life science companies, payers, and patients.
Apr 27, 2023
39 min
Load more